Research Article
Volume 13 Issue 1 - 2021
Serum Uric Acid Level and Its Effect on Short Term Functional Outcome of Acute Stroke and TIA: Prospective Single Center Study
Amal M Al Hashmi BSc, MD , FRCPC1*, Ahmed Al Saadi2, Mahmood Al Hinai2, Ahmed Al Sinani MD3, Sachin Jose4,  Noora  Al Jahwari5, Emma  Gallano5 and  Jaypee Sicat5
1Sr Consultant Neurologist, Chief Central Stroke Unit, Neuroscience Directorate, Khoula Hospital, Ministry of Health of Oman, Muscat, Oman
2Neurology Resident, Oman Medical Specialty Board OMSB, Muscat, Oman
3General Foundation Program Neurology, Oman Medical Specialty Board, Muscat, Oman
4Statistical Specialist, Oman Medical Specialty Board, Muscat, Oman
5Stroke Nurse at the Central Stroke Unit, Khoula Hospital, Muscat, Oman
*Corresponding Author: Amal M Al Hashmi BSc, MD , FRCPC, Sr Consultant Neurologist, Chief Central Stroke Unit, Neuroscience Directorate, Khoula Hospital, Ministry of Health of Oman, Muscat, Oman.
Received: November 07, 2020; Published: December 31, 2020


Background: The association between high serum uric acid (SUA) level and cardiovascular diseases (CVD) such as stroke is not well established. Additionally, the effect of high SUA and stroke functional out- come and prognosis remains controversial. Further large-scale studies are needed. 

Objective: This study aims to assess the short-term  functional outcome  of patients admitted with acute stroke or  Transient Ischemic attack (TIA) and  elevated SUA. Additionally, it  aims to  deduce whether there is a trend  or a  relationship between the elevated SUA level, and stroke subtypes and TIA. 

Method: This is a  prospective observational single center hospital-based study performed at the Central Stroke Unit over 13 months period.  Starting January  2014 and ending January 2015. After obtaining the ethical approval by the hospital’s research committee; patient’s data was collected in an excel sheet.   The diagnosis of acute stroke or TIA for all included patients was confirmed by detailed history, examination, and brain imaging (CT or MRI).  Both ischemic and intracranial hemorrhage subtypes were included as well as TIA. Only confirmed acute stroke or TIA cases with SUA done withing 48 hours of admission date that  match all the inclusion and exclusion criteria were included.

Results: The final sample size was 187, they were 129, (69%) patients diagnosed with ischemic stroke (IS), 23 (12.3%) with intracranial hemorrhage (ICH) and 35(18.7%) with TIA. The mean age was 59.1 years of age. There were 111 men and 76 women. Elevated SUA was only found in 41 patients (36%) versus 73 (64%) patients with normal SUA level. There were 16 women with elevated SUA versus  25 men. Out of the 41 patients with elevated SUA and acute stroke or TIA; 26 had IS, and 10 had ICH and 5 with TIA.  The length of admission ranged between 4-11 days, with a median of 6 days. 70.3% of the patients had moderate to severe disability upon admission, versus 47.6% upon discharge. Nine patients (4.9%) were died.

Conclusions: In this study, although elevated SUA level was not associted with worsening short term functinal out come for patients  admitted with  acute stroke or TIA. It is  hard to draw a pricese conclusion due to the  small smaple size. Therefore further large scale and multicenter studies are needed.

Keywords: Serum Uric Acid;  Acute Stroke; Ischemic Stroke;  Intracranial Hemorrhage; Transient Ischemic Attack; Modified Rankin Scale


  1. Baker JF., et al. “Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?” The American Journal of Medicine 118 (2005): 816-826.
  2. Becker M and Jolly M. “Hyperuricemia and associated diseases”. Rheumatic Diseases Clinics of North America 32 (2006): 275-293.
  3. Wannamethee S. “Serum uric acid and risk of coronary heart disease”. Current Pharmaceutical Design 11 (2005): 4125-4132.
  4. Feig D., et al. “Uric acid and cardiovascular risk”. The New England Journal of Medicine 359 (2008): 1811-1821.
  5. Culleton B., et al. “Serum uric acid and risk of cardiovascular disease and mortality: the Framingham Heart Study”. Annals of Internal Medicine 31 (1999): 7-13.
  6. Kanellis J and Johnson R. “Elevated uric acid and ischemic stroke: accumulating evidence that it is injurious and not neuroprotective”. Stroke 34 (2003): 1956-1958.
  7. Weir C., et al. “Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke”. Stroke 34 (2003): 1951-1957.
  8. Lehto S., et al. “Serum uric acid is a strong predictor of stroke in patients with non-insulin dependent diabetes mellitus”. Stroke 29 (1998): 635-639.
  9. Mazza A., et al. “Predictors of stroke mortality in elderly people from the general population: the Cardiovascular Study in the Elderly”. European Journal of Epidemiology 17 (2002): 1097-1104.
  10. Fang J and Alderman M. “Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992”. The Journal of the American Medical Association 283 (2000): 2404-2410.
  11. Niskanen L and Laaksonen D. “Nyyssonen uric Acid Level as a Risk Factor for Cardiovascular and All -Cause Mortality in Middle aged Men Aprospective Cohort Study”. JAMA Internal Medicine 14 (2004): 1546-1551.
  12. Kim SY., et al. “Hyperuricemia and risk of stroke: a systematic review and meta-analysis”. Arthritis and Rheumatology 61 (2009): 885-892.
  13. Koppula R., et al. “Association of serum uric acid level with ischemic stroke, stroke subtypes and clinical outcome”. Neurology Asia4 (2013): 349-353.
  14. Dhrubajyoti Bandyopadhyay., et al. “Prognostic Significance of Serum Uric Acid at the Time of Admission in Patients with Acute Stroke”. American Journal of Clinical Medicine Research2 (2015): 24-30.
  15. Zhong C., et al. “Sex-specific relationship between serum uric acid and risk of stroke: a doseresponse meta-analysis of prospective studies”. Journal of the American Heart Association 6 (2017): pii: e005042.
  16. Daskapoulou SS., et al. “Uric acid levels and vascular disease”. Current Medical Research and Opinion 20 (2004): 951-954.
  17. Mapoure YN., et al. “The prognostic value of serum uric acid in the acute phase of hemorrhagic stroke patients in black Africans”. Pan African Medical Journal 32 (2019): 165.
  18. Barr WG. “Uric Acid”. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods. The History, Physical, and Laboratory Examination, 3rd edition. Boston: Butter worth (1990): 760-763.
  19. Hariklia VD., et al. “The Role of Uric Acid in Stroke. The Issue Remains Unresolved”. The Neurologist 14 (2008): 238-242.
  20. Heo SH and Lee SH. “High levels of serum Uric acid are associated with silent brain infarction”. Journal of Neurology and Experimental Neural Science 297 (2010): 6-15.
  21. Romanos E., et al. “Uric acid reduces brain damage and improves the benefits of rtPA in a rat model of the thromb-embolic stroke”. Journal of Cerebral Blood Flow and Metabolism 27 (2007): 14-20.
  22. Kamei K., et al. “Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study”. Clinical and Experimental Nephrology 21 (2017): 497-503.
  23. Sakata K., et al. “Absence of an association between uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National Integrated Projects for prospective observation of non-communicable diseases and its trend in the aged”. European Journal of Epidemiology 17 (2001): 461-468.
  24. Saadat P., et al. “Relationship of Serum Uric Acid Level with Demographic Features, Risk Factors, Severity, Prognosis, Serum Levels of Vitmain D, Calcium and Magnesium in Stroke”. Stroke and Research Treatment (2018): 1-8.
  25. Milionis HJ and Elisaf MS. “Management of hypertension and dyslipidemia in patients presenting with hyperuricemia: case histories”. Current Medical Research and Opinion 16 (2000): 164-170.
  26. Hoiggen A., et al. “LIFE Study Group. The impact of serum uric acid on cardiovascular outcomes in the LIFE study”. Kidney International 65 (2004): 1041-1049.
Citation: Amal M Al Hashmi BSc., et al. “Serum Uric Acid Level and Its Effect on Short Term Functional Outcome of Acute Stroke and TIA: Prospective Single Center Study”. EC Neurology 13.1 (2021): 34-41.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 08, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to